NTFs including ciliary neurotrophic factor (CNTF), BDNF, insulin-like growth factor 1 (IGF-1), NGF, glial cell line-derived neurotrophic factor (GDNF), and neurturin (NRTN) have been delivered via subcutaneous, intrathecal, intraventricular, and IP routes of administration to patients with amyotrophic lateral sclerosis (ALS), PD, Alzheimer's Disease, and peripheral neuropathies (152). The gene discussed is IGF1; the disease is Parkinson disease.